Literature DB >> 7819905

ABC of breast diseases. Prognostic factors.

W R Miller1, I O Ellis, J R Sainsbury, J M Dixon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7819905      PMCID： PMC2541740          DOI： 10.1136/bmj.309.6968.1573

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer.

Authors:  W R Miller; D M Watson; W Jack; U Chetty; R A Elton
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872
  1 in total
  12 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Usefulness of serum CA 15.3 and histopathological prognostic indices in breast cancer.

Authors:  R Nalini; C R Wilma Delphine Silvia; Purnima M Makhija; Sheila Uthappa
Journal:  Indian J Clin Biochem       Date:  2005-01

3.  The value of metastatic screening in early primary breast cancer.

Authors:  M C Barry; F Thornton; M Murphy; F Younis; R G Watson
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

4.  (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.

Authors:  Eun Jung Kong; Kyung Ah Chun; Ihn Ho Cho; Soo Jung Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-06-15

Review 5.  Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.

Authors:  Samuel L Rice; Kent P Friedman
Journal:  PET Clin       Date:  2016-10

6.  Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.

Authors:  C H van Gils; J D Otten; A L Verbeek; J H Hendriks; R Holland
Journal:  J Epidemiol Community Health       Date:  1998-04       Impact factor: 3.710

7.  Expression of proteinases and inhibitors in human breast cancer progression and survival.

Authors:  E A Baker; T J Stephenson; M W R Reed; N J Brown
Journal:  Mol Pathol       Date:  2002-10

8.  Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.

Authors:  Till A Heusner; Sherko Kuemmel; Steffen Hahn; Angela Koeninger; Friedrich Otterbach; Monia E Hamami; Klaus R Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-05       Impact factor: 9.236

9.  MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.

Authors:  D C Jinga; A Blidaru; Ileana Condrea; Carmen Ardeleanu; Cristina Dragomir; G Szegli; Maria Stefanescu; Cristiana Matache
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

10.  Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.

Authors:  Judy A King; Solomon F Ofori-Acquah; Troy Stevens; Abu-Bakr Al-Mehdi; Oystein Fodstad; Wen G Jiang
Journal:  Breast Cancer Res       Date:  2004-06-28       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.